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Dietary Canola Oil Suppressed Growth of Implanted
MDA-MB 231Human Breast Tumors in Nude Mice
W. Elaine Hardman
Abstract: Long chain omega 3 (n-3) fatty acids, eicosapentaenoic (EPA) and/or docosahexaenoic acid (DHA), have been shown to suppress growth of most cancer cells. In vivo, alpha linolenic acid (ALA, 18:3n-3) can be converted to EPA or DHA. We hypothesized that substituting
canola oil (10% ALA) for the corn oil (1% ALA) in the diet of cancer bearing mice would slow
tumor growth by increasing n-3 fatty acids in the diet. Sixty nude mice received MDA-MB 231
human breast cancer cells and were fed a diet containing 8% w/w corn oil until the mean tumor
volume was 60 mm3. The dietary fat of half of the tumor bearing mice was then changed to 8%
w/w canola oil. Compared to mice that consumed the corn oil containing diet, the mice that
consumed the canola oil containing diet had significantly more EPA and DHA in both tumors
and livers, and the mean tumor growth rate and cell proliferation in the tumor were significantly
slower (P < 0.05). About 25 days after diet change, mice that consumed the corn oil diet stopped
gaining weight, whereas the mice that consumed the canola oil diet continued normal weight
gain. Use of canola oil instead of corn oil in the diet may be a reasonable means to increase
consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer
cells in cancer survivors.
Introduction
Supplementing the diet of cancer bearing mice with fish oil has been shown to reduce the
growth rate of multiple tumor types and to increase the efficacy of various cancer chemotherapies (briefly reviewed in [1]). Fish oil is high in long chain (20 and 22 carbons) omega 3 polyunsaturated fatty acids. Testing of individual fatty acids in cell culture indicates that overall the
eicosapentaenoic (EPA, 20:5n-3) and/or docosahexaenoic (DHA 22:6n-3) fractions of fish oil are
the fractions of fish oil that are directly active for suppressing cancer cell growth via multiple
mechanisms (1).
The double bond at the omega 3 position is generated in plants but not in fish or mammals. The alpha linolenic acid (ALA, 18:3n-3) that is consumed by fish from plant or algae
sources is desaturated and elongated to EPA and DHA for incorporation into cell membranes of
fish. Thus, even though oils derived from fish are high in EPA and DHA, plant derived dietary
ALA was the source of these longer chain fatty acids.
Humans and mice are also capable of desaturating and elongating 18 carbon fatty acids,
of either the n-6 or n-3 derivation, to 20 or 22 carbon fatty acids. Linoleic acid (LA 18:3n-6) is
converted to arachidonic acid (AA, 20:4n-6), whereas ALA is converted to EPA,
docosapentaenoic (DPA, 22:5n-3), and DHA. The efficiency of conversion of ALA to longer
chain fatty acids is varying and not completely known; however, there is some evidence that
conversion of ALA to longer chain fatty acids in humans may be more efficient than previously
thought (2). We hypothesized that incorporating ALA in the diet of mice, at levels that humans
might reasonably consume would be beneficial for slowing the growth of an implanted cancer.
In dietary studies, it seems important to use a source of ALA that could be used routinely
in the diets of humans. Flaxseed oil (linseed oil) contains 50 to 60% ALA and about 15 to 20%
linoleic acid, is an excellent source of ALA and consumption of flaxseed has been shown to slow

growth of cancers implanted in mice (3). However, flaxseed oil is expensive (in the range of $15
per liter), is not readily available in grocery stores, has a somewhat bitter taste, and is not recommended for cooking uses. Canola oil (rapeseed oil) costs about the same as corn oil (about $2 per
liter), is readily available in grocery stores, and can be used in cooking, baking, and salad dressings. It contains about 10% ALA and 20% LA, not nearly as much ALA as flaxseed, oil, but
could be a realistic, cost-effective means of increasing of omega 3 fatty acids in the human diet.
Since corn oil contains 55 to 60% LA and less than 1% ALA, the routine use of canola oil
instead of corn oil would improve the omega 6 to omega 3 ratio in the diet.
This study was designed to determine whether removing corn oil and substituting with
canola oil in the diet would provide the cancer growth suppressive benefits linked to long chain
omega 3 fatty acids.
Table 1. Diet Composition
g/kg Diet
% of Total Energy
kcal/kg1 Dry Weight
Energy J/g2 Dry wt
_____________________________________________________________________________________________________________________
Casein
200
Sucrose
470
Corn starch
150
Alphacel
50
Choline bitartrate
2.0
DL-methionine
3.0
AIN-76 mineral mix
35.0
AIN-76A vitamin mix 10.0
Either corn or canola oil 80.0
Totals

19.3
45.3
14.5
0
0
0
0.4
1.0
19.4
99.9

716
1682.6
540
0
0
0
16.5
39.2
720
3714.3

3.00
7.05
2.26
0
0
0
0.07
0.16
3.01
15.55

1

Caloric density calculated from values supplied on Dyets, Inc., website: http://dyets.com/caloric.htm.
Calculated 1kcal/g = 4.187 J/g.

2

Methods and Materials

Preparation of Cells for Injection
Cultured MDA-MB 231 cells (American Type Culture Collection, Rockville, MD) were
harvested, rinsed, then suspended in serum-free, antibiotic-free L-15 base culture medium
(American Type Culture Collection, Rockville, MD). Cells in suspension were counted using a
hemocytometer, and the cell count was adjusted to 20 × 106/ml. The suspension was kept well
mixed during the time of injection. MDA-MB 231 cells (1 × 106 cells in 0.05 ml of serum free
media) were injected sc between the scapulae of each mouse.

Dietary Fats
Corn oil contains about 60% linoleic acid, 23% oleic acid, and 10% C16 fatty acids (>6
mg/g n-3 PUFAs). The composition of the canola oil is about 20% linoleic acid, 10% alpha
lenolenic acid, and 50% oleic acid. Both corn oil and canola oil were obtained at a local grocery
store and were without added antioxidant. Opened bottles of oil were stored at 4◦C.

Animals and Diet
Sixty female athymic nu/nu mice (Harlan Sprague Dawley, Inc., Madison, WI), 3 mo old,
received tumor cells. The mice were housed 4/box under aseptic conditions in a temperature
(24◦C) and light-controlled (12 h/day) room. All animal use and handling was approved by the
Pennington Biomedical Research Center Institutional Animal Care and Use Committee.
The compositions of the diets are given in Table 1. All mice were fed the AIN-76A
semipurified diet modified to contain 8% w/w corn oil from receipt until 3 wk after injection
of cells to allow the tumors to become established. Forty-eight nude mice bearing growing
MDA-MB-231 human breast carcinoma xenografts were then divided into 2 dietary groups such
that the mean tumor size was not different between groups. Twenty-four mice were placed on the
AIN-76A diet modified to contain 8% w/w canola oil. Diets were prepared monthly, daily portions were individually packaged and stored at −80◦C in sealed containers to prevent lipid peroxidation. All mice were fed a measured amount of fresh food each day, and food remaining in the
cage was discarded.

Tumor and Body Weight Measurements
Lengths, widths, and depths of the subcutaneous tumors and body weights were measured 3
times weekly using digital calipers (Fred W. Fowler Co., Newton, MA) and an electronic scale
(Ohaus, Pinebrook, NJ), respectively. The instruments were connected to a laptop computer and
all measurements were entered directly into an Excel spreadsheet by the instruments. The subcutaneous, mid-scapular location of the tumor allowed a good estimate of the depth of the tumor.
Tumor sizes were calculated using the formula for the volume of a prolate spheriod: V = 4/3 *
3.14 * L/2 *W/2 * D/2.

Necropsy and Tissue Processing
Euthanasia was by isoflurane inhalation, then cervical dislocation. The tumor and liver were
removed at necropsy. Portions of each tissue were fixed for histology, and the remaining portion
was placed in an individually labeled vial and flash frozen in liquid nitrogen. At a later date,
frozen livers or tumor were thawed and homogenized individually at 4◦C using a Polytron homogenizer (Brinkmann Kinematica Polytron from Fisher Scientific, IL) then divided into aliquots
for subsequent analyses.

Gas Chromatography (GC)
The fatty acid compositions of cell membranes of liver and tumor were determined in 10 mice
that consumed each diet. Samples were individually homogenized, and membranes were
separated by ultracentrifugation. Chloroform:methanol was used for lipid extraction of each
fraction; lipids were methylated and esterified in acetyl chloride-methanol as described (4). Gas
chromatography was done using a Hewlett Packard 5890 Series 11 Gas Chromatograph (Palo
Alto, CA) and conditions of: oven temperature ramp 1 at 150◦C for 15 min, ramp 2 at 175◦C for

15 min, then ramp 3 at 225◦C for 7 min, injector temperature at 225◦C, flame-ionization detector
at 250◦C, helium carrier gas at 42.3 psi. Fatty acid methyl ester standards (Nu-Chek-Prep, lysian,
MN) were used for peak identification. The fatty acid methyl esters were reported as the percent
of the total methylated fatty acids (area under the curve).

Immunohistochemistry for PCNA and COX-2
Immunohistochemical analyses for expression of proliferating cell nuclear antigen (PCNA) and
cyclooxygenase 2 (COX-2) were performed on serial 4 μm thick histologic sections of the tumor.
Standard immunohistochemical technique was employed using PC-10 (Biogenex, San Ramon,
CA) as primary antibody for PCNA and PG27B (anti-PGHS 2, Oxford Biomedical Research,
Oxford, MI) as primary antibody for COX-2. Secondary (anti-mouse or anti-rabbit IgG linked to
biotin) and labeling (streptaviden-peroxidase) antibodies were from Biogenex (SuperSensitive
Detection Kit, San Ramon, CA). Diaminobenzedine was used for the label. The number of
PCNA positive cells in at least 500 cells in viable areas of 10 tumors were counted to determine
the PCNA positive fraction of tumors from mice that consumed each diet. The presence of COX2 was assessed on a scale of 0 to 4 with 0 being absent and 4 being heavily staining for COX-2.
An observer blinded to the diet group assessed 5 fields in viable areas of each tumor using a 40×
objective.

Statistical Analyses
PRISMTM (GraphPad Software, San Diego, CA) software was used for statistical analyses. Tests
for normality (basic statistics) were used on each data set. A t -test was used to determine
statistically significant (P ≤ 0.05) differences in parametric parameters due to incorporation of
corn or canola oil into the diet. A non-parametric Mann-Whitney test was used for differences in
data (COX-2 expression) that did not meet the criteria for normality. PRISMTM was also used to
generate a linear regression of linear portions (the latter half) of tumor growth and body weight
curves. A t –test was used to test for differences between the slopes of the linear portions of the
body weight and tumor growth curves.

Results

Effects due to increased omega 3 in the diet would not be expected to be seen until omega 3 fats
had been incorporated into cell membrane phospholipids to be available for use as substrate for
cell signaling molecules. Since the diet contained such a small amount of omega 3 fatty acid, it
was expected that accumulation of significant amounts of EPA and DHA in the cell membranes
would take 2 to 3 wk. Mouse weight and tumor growth rates began to diverge about 25 days
after canola oil was incorporated into the diet of one group of mice. Thus day 25 was used as the
cut point for calculation of effects of the diet on body weight and tumor growth.

Fatty Acid Content of Diet and of Tissues
Table 2. Polyunsaturated Fatty Acid Compositions of Oils Used in the Diets (% of total fatty acids)

Corn Oil
Canola Oil
______________________________________________________________________________
Linoleic acid (18-3:n-6)
57.00
21.00
Alpha linolenic acid (18-3:n-6)
1.000
11.00
Arachidonic acid (20-4:n-6)
0.080
0.16
Eicosapentaenoic acid (20-5:n-3)
0.170
0.22
Docosahexaenoic acid (22-6:n-3)
0.000
0.00
______________________________________________________________________________

As expected, gas chromatography (Table 2) demonstrated that the fat in the diet containing 8% w/w corn oil was pre dominately omega 6 linoleic acid (57%) and that the corn oil diet
contained only about 1% omega 3 fatty acids in the form of ALA. The fat in the diet containing
8% w/w canola oil, however, contained 21% omega 6 linoleic acid and about 11% ALA. The n-6
to n-3 ratio of the corn oil diet was 57:1 and of the canola oil diet was about 2:1. Neither the corn
oil nor the canola oil contained appreciable amounts of either eicosapentaenoic (EPA) or docasahexaenoic (DHA). The polyunsaturated fatty acid composition of the tumor and liver changed
significantly due to the diet (Figs. 1A and 1B). The EPA and DHA (omega 3 fatty acids) content
of both tumor and liver were significantly (P < 0.05) higher and linoleic and arachidonic acid
(omega 6 fatty acids) were significantly (P < 0.05) lower in mice that consumed the canola oil
diet than in mice that consumed the corn oil diet. Since the diet did not contain EPA or DHA, the
source of the increased EPA and DHA in mice that consumed the canola oil diet must have been
conversion from dietary ALA.

Mouse Body Weights
Figure 2 illustrates the mouse body weights. The mean body weights of the 2 groups of
mice may began to diverge about day 12 but have certainly diverged by day 25. The initial body
weights of the 2 groups of mice are not different, but at the end of the study, the final body
weights were significantly different. The rates of gain for the last 32 days were also significantly
different. The group that consumed canola oil continued to gain weight at about the same rate,
0.06 ± 0.02 g/day (mean ± SD) as during the first 25 days. However, linear regression from day
25 to day 57 indicated that the group that consumed the corn oil diet gained less weight. The rate
of weight gain from day 25 to day 57 was 0.02 ± 0.02 g/day, a rate that was significantly
(P<0.05) less than the rate of weight gain of the canola oil group.

Growth Rate of the Tumors
The growth of the tumor was not expected to be altered until omega 3 dietary fatty acids
(especially EPA and DHA) had accumulated in cell membranes. The tumor growth curves (Fig.
3) show that perhaps by day 10 but certainly by day 25, the tumor growth rates of the 2 groups
began to diverge indicating that sufficient omega 3 had accumulated for the tumor growth to be
affected. The tumor growth rates for the first 25 days are not different and the complete tumor
growth curves are obviously not linear if assessed from the first day of diet change until the end
of the experiment. However, the growth curve is approximately linear (see Fig. 3) from day 25
until the end of the experiment and linear regression of tumor growth from day 25 to day 57 (the
end of the experiment) was used to estimate the tumor growth rate. The mean ( ± SEM) tumor
growth rate of the mice that consumed the corn oil diet was 7.5 ± 0.8 mm3/day, whereas the
mean tumor growth rate of mice that consumed the canola oil diet was 3.2 ± 0.4 mm3/day. A t test of growth rates from day 25 to day 57 indicated that the mean growth rates of the two groups
were significantly different, P <0.001.

Figure 1. Fatty acid compositions of the tumor (A) and liver (B) of mice fed
diets containing either 8% corn oil or 8% canola oil. The percent of the total
membrane fatty acids (means ± SEM) of major omega 6 (linoleic and arachidonic)
and omega 3 (linolenic, eicosapentaenoic, and docosahexaenoic) fatty acids are shown.
Error bars are given, but are so small that they may disappear into the top of the column.

Figure 2. Mean body weights (g ± SEM) of tumor bearing mice that
consumed diets containing 8% corn oil or 8% canola oil. Day 0 is the day
of diet change.

Proliferation and Tumor Volume
Proliferation was significantly (p = .0025) slower in tumors of the mice that consumed
the canola oil diet. The PCNA positive fraction in viable areas of the tumors of mice that consumed the corn oil diet was 8.8 ± 2.7% (mean % ± SD) and in the tumors of mice that consumed
the canola oil diet the fraction was 4.1 ± 2.2%.
At the time of euthanasia, the mean volume of the tumors of the group that consumed
canola oil (126 mm3) was less than 1/2 the mean volume of the tumors of the group that consumed corn oil (297 mm3). This was not quite significantly (p = 0.12) different. The time of
euthanasia was determined by the time at which several mice in the corn oil fed group had

Figure 3. Mean tumor volume (mm3) of mice that consumed diets containing 8%
corn oil or 8% canola oil. Day 0 is the first day of the canola oil diet. The linear regression
lines superimposed on the data illustrate the mean growth rate of the tumors of each group
from day 25 until the end of the study. The rates of growth of the tumors of the mice that
consumed corn oil is significantly (P <0.05 by t -test of the slopes of the linear regressions)
greater than the rate of growth of the tumors of mice that consumed canola oil.

tumors so large that euthanasia was required. Given the large difference in tumor growth
rates and in tumor cell proliferation between the two groups, had the experiment been continued,
the final volumes would have been significantly different.

Figure 4. The mean COX-2 stain intensities in viable areas of the tumor
were not significantly different due to the diet of the mice.

COX-2 in the Tumor
Long chain omega 3 fatty acids have been shown to suppress COX-2 expression in tumors.
Immunohistochemistry was used for semi-quantitative assessment of the expression of COX-2 in
the tumor (Fig. 4). A Mann-Whitney test showed that there was not a significant difference in the
median stain due to the diet of the mice.
Discussion
The composition and amount of dietary fat has been shown to alter the tumor growth rate in
numerous animal studies (briefly reviewed in [1]). High amounts of dietary omega 6 fatty acids
(especially linoleic acid) increase the growth rate of most tumor types compared to the growth
rate of the tumor with lower amounts of omega 6 fatty acids in the diet. Consumption of long
chain omega 3 fatty acids (i.e., fish oils containing EPA and DHA) has been shown to result in
slower tumor growth than consumption of an equivalent amount of omega 6 fatty acids in the
diet (5). Flaxseed at 10% w/w of the diet has been shown to slow growth of human breast
cancers in animal models (3). The fat composition of that diet was not reported. However the fat
composition of that diet can be approximated since flaxseed contains 54% fat. Flaxseed oil
contains about 55% ALA thus about 30% w/w of the flaxseed or about 3% w/w of that diet was

ALA. In comparison about 0.8% of the test diet for this study was ALA. Humans do not
consume 20% w/w of the diet as fish oil or as flaxseed, although a small amount of these sources
of omega 3 fatty acids can be added to the diet.
We hypothesized that a dietary change that humans might reasonably make, that of using
canola oil instead of corn oil in the diet, would make a difference in the growth rate of cancers.
We selected an 8% w/w corn oil diet as one that would include an amount of linoleic acid that is
a more reasonable estimate for human linoleic acid consumption than found in the 20% w/w corn
oil diets used in many previous experiments. A value that has been used for the average
American diet is that 6.6% of energy is from LA (2). The corn oil diet in this study contained
9.7% energy from LA, whereas the diet containing 20% w/w corn oil would derive about 24% of
energy from linoleic acid. Substituting canola oil for the corn oil in the diet reduced the amount
of LA and decreased the n-6 to n-3 ratio from about 57:1 to 2:1. To our knowledge, this is the
first report indicating that substituting canola oil for the corn oil in the diet may have benefit for
slowing the growth of cancers.
We expected that the ALA of the canola oil would have to be elongated and desaturated
to EPA and DHA before there would be any effect on tumor growth. There was almost no EPA
or DHA in the dietary fat. The data indicate that the ALA in the canola oil was elongated and
desaturated for incorporation into the membrane phospholipids as EPA and DHA since the fatty
acid compositions of both tumor and liver of mice that consumed the canola oil diet contained
significantly more EPA and DHA than did the tumor and liver of mice that consumed the corn
oil diet. Surprisingly, ALA was slightly decreased in the tissues of the group that consumed
canola oil. This may indicate that most ALA was being converted to EPA and DHA rather than
being stored as ALA. As expected, the LA and AA acid content of the tumor and liver of the
group that consumed canola oil was significantly less than that of the group that consumed
canola oil.
Consumption of long chain omega 3 fatty acids has been associated with decreased tumor
associated cachexia (6–9). The graph of body weights (Fig. 2) indicates that the mean body
weights of the 2 groups began to diverge about 25 days after the start of the dietary interventions.
This is also about the same time as the tumor sizes began to diverge. Since tumors were larger in
the group that consumed the corn oil containing diet, if the weight of the tumor had been subtracted, the differences between the mean body weights of the two groups would have been even
more pronounced. We hypothesize, but do not know, that body weight gain continued in the
group that consumed canola oil because the tumor size was smaller and there was less production
of cytokines related to cachexia (9–13). This is an area to be investigated in the future.
Once omega 3 fatty acids were incorporated into the cell membranes of the mouse, the
tumor growth rates began to diverge. During the second half of the project, the mean growth
rate of the tumors of the mice that consumed canola oil was significantly less than the growth
rate of the tumors of the mice that consumed corn oil. Our analyses of proliferation by PCNA
immunohistochemistry indicated that a likely cause of the slower growth of the tumor was the
decrease in tumor cell proliferation. The tumor volumes were not quite significantly different at
the end of this study, however given the significant differences in growth rates and tumor cell
proliferation, had the study continued for the longer time, the final tumor volumes would have
been significantly different. Long chain omega 3 fatty acids have been shown to suppress
proliferation in other studies (for example, [14]).
The expression of COX-2was slightly but not significantly suppressed in the tumor as
assessed by semi-quantitative analyses of immunohistochemical staining. The proliferation

promoting eicosanoid, PGE2 is a product of COX-2 action on AA, whereas proliferation suppressing PGE3 is a product of COX-2 action on EPA. Production of PGE2 or PGE3 could not be
assessed in this study; however, one does wonder if the combination of reduced COX-2 activity
and decreased AA would have significantly reduced the amount of PGE2 present in the tumor.
SinceCOX-2 is at the beginning of a signaling cascade, further studies should be done to
determine whether decreasedCOX-2 expression (even though not mathematically significant)
could have biological significance for suppression of cytokines that promote cell proliferation.
There are 2 sets of reports of potentially detrimental effects of canola oil consumption
that must be acknowledged and weighed with the evidence in this report. One set involves
feeding canola (rapeseed) oil to stroke-prone spontaneously hypertensive rats (15–19). In these
reports, canola oil consumption has been associated with reduced lifespan of the rats. These rats
have a deficiency in membrane cholesterol that makes red cell membranes weak and fragile (17).
Thus, the rats are very sensitive to reduced dietary cholesterol and the phytosterols in canola oil
can inhibit the absorption of dietary cholesterol (17). Increase consumption of phytosterols was
associated with early death of the rats in two reports (15,17). The renal injury seen in one report
(18) is also consistent with fragile cells. Reduced dietary cholesterol is not usually a problem in
humans, and one author commented that there was no direct evidence that the effects in rats
related to human nutrition (19).
The other set of reports involves an increased risk for lung cancer among Chinese women
who used unpurified canola oil (20–23) for stir frying. In these reports the increased risk was
associated with excessive exposure to smoke from the high cooking temperatures. It is not clear
if the carcinogens generated were from the meat being stir fried by generation of heterocyclic
amines (22) or from carcinogens associated with the oil, though it was indicated that the risk
seemed to increase with the use of canola oil, (21,23). It is unlikely that canola oil used in stir
frying would effective suppress tumor growth, since the oil ingested would be highly oxidized
and broken down to shorter chain fatty acids.

Conclusions
These data indicate that:
1. Substituting canola oil for the corn oil in the diet can serve as a source of omega 3 fatty acids
for suppression of tumor growth. The mechanisms for growth suppression were not identified
and remain for further study.
2. Gas chromatography indicated that the α-linolenic acid obtained from the canola oil was
effectively converted to EPA and DHA for incorporation into tumor and host tissues.
The importance of this study is that increasing the consumption of canola oil, a source of
omega 3 fatty acids, and reducing the consumption of corn oil is a dietary change that could
easily be incorporated into the Western diet. It has been proposed that omega 3 fatty acids may
be effective cancer preventive agents (24). Especially in conjunction with increased fish consumption, diet recommendations to include canola oil could reduce the risk for or slow the
growth rate of cancer in future generations.
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